The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate.
The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones.
Participants will
ingest fixed diets containing low amounts of oxalate for 5 days ingest a soluble form of glycolate and vitamin C collect urine, blood, stool during the dietary and oral dosing portions of the study and also collect breath sample during the oral glycolate test
age 18-80 yrs
Body Mass Index > 18.5 kg/m2
Normal fasting serum electrolytes on comprehensive metabolic profile
Willing to ingest fixed diets
Chronic Kidney Disease stage 4-5
Primary hyperoxaluria, Enteric (secondary) hyperoxaluria
Liver, bowel, endocrine or renal diseases (other than idiopathic Calcium Oxalate kidney stones) or any other condition that may influence the absorption, transport or urinary excretion of ions, which will compromise the interpretation of results, including: Cystic fibrosis, Celiac disease, Cystinuria, Uric acid stone former, Nephrotic syndrome, Sarcoidosis, Renal tubular acidosis, Primary hyperparathyroidism, Neurogenic bladder, Urinary diversion, Chronic diarrhea, Bariatric surgery, Inflammatory bowel disease
Pregnancy or breast-feeding
University of Alabama at Birmingham
Lead sponsor
University of Texas, Southwestern Medical Center at Dallas
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator